Alanko, T., Hemminki, A., Cervera-Carrascón, V., Havunen, R., Taipale, K., Quixabeira, D. C. A., . . . Santos, J. M. Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: Mechanistic and biomarker findings from TUNIMO phase I trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationAlanko, Tuomo, et al. Transient Lymphocyte Count Decrease Correlates with Oncolytic Adenovirus Efficacy in Humans: Mechanistic and Biomarker Findings from TUNIMO Phase I Trial. BMJ Publishing Group.
MLA (9th ed.) CitationAlanko, Tuomo, et al. Transient Lymphocyte Count Decrease Correlates with Oncolytic Adenovirus Efficacy in Humans: Mechanistic and Biomarker Findings from TUNIMO Phase I Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.